TSE:MBX Microbix Biosystems (MBX) Stock Price, News & Analysis → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free MBX Stock Alerts C$0.33 +0.01 (+1.54%) (As of 03:48 PM ET) Add Compare Share Share Today's RangeC$0.32▼C$0.3350-Day RangeC$0.33▼C$0.4152-Week RangeC$0.23▼C$0.47Volume194,209 shsAverage Volume71,757 shsMarket CapitalizationC$45.06 millionP/E Ratio11.00Dividend Yield2.30%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Microbix Biosystems alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Microbix Biosystems Stock (TSE:MBX)Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.Read More MBX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBX Stock News HeadlinesApril 25, 2024 | markets.businessinsider.comMicrobix Collaborator Introduces New Lab Accreditation ProgramApril 11, 2024 | finance.yahoo.comMicrobix Presenting at the 2024 Bloom Burton ConferenceApril 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...April 1, 2024 | finance.yahoo.comMicrobix Announces Annual and Special Meeting Voting ResultsMarch 14, 2024 | finance.yahoo.comMicrobix’s Clot-Buster Drug Project AdvancesMarch 11, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Controls for Head and Neck CancerMarch 11, 2024 | ca.finance.yahoo.comStocks in play: Microbix Biosystems Inc.March 1, 2024 | wsj.comMicrobix Biosystems Inc.April 29, 2024 | InvestorPlace (Ad)Have You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...February 26, 2024 | finance.yahoo.comMicrobix Announces Issuance of Stock OptionsFebruary 17, 2024 | finance.yahoo.comMicrobix Biosystems First Quarter 2024 Earnings: EPS: CA$0.018 (vs CA$0.009 loss in 1Q 2023)February 14, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Reports Record Results for Q1 Fiscal 2024February 14, 2024 | finance.yahoo.comMicrobix Reports Record Results for Q1 Fiscal 2024February 7, 2024 | finance.yahoo.comMicrobix Schedules Release of Results for Q1 Fiscal 2024February 6, 2024 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Unveils Test Control for Gastric Ulcer Disease PathogenFebruary 6, 2024 | finance.yahoo.comMicrobix Unveils Test Control for Gastric Ulcer Disease PathogenJanuary 3, 2024 | finance.yahoo.comMicrobix Achieves Further QAPs Sales RecordDecember 22, 2023 | finance.yahoo.comMicrobix Biosystems Full Year 2023 Earnings: Revenues Miss ExpectationsDecember 21, 2023 | finance.yahoo.comMicrobix Reports Results for Q4 & Full-Year Fiscal 2023December 14, 2023 | finance.yahoo.comMicrobix & Seegene USA Jointly Enhancing Lab Test AccuracyDecember 7, 2023 | finance.yahoo.comMicrobix & BioGX Collaborate on real-time PCR Assays & ControlsNovember 17, 2023 | financialpost.comMicrobix Presenting at Florida Capital Event ConferenceNovember 16, 2023 | finanznachrichten.deMicrobix Biosystems Inc.: Microbix Clot-Buster Drug Fully-Funded For Return to U.S. MarketNovember 16, 2023 | finance.yahoo.comMicrobix Clot-Buster Drug Fully-Funded For Return to U.S. MarketNovember 10, 2023 | finance.yahoo.comMicrobix & Ulisse Biomed Collaborate on HPV Controls & AssaysOctober 27, 2023 | finance.yahoo.comMicrobix QAPs Supporting HPV Testing in IrelandOctober 21, 2023 | investing.comMicrobix Biosystems Inc. (MBX)See More Headlines Receive MBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbix Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/14/2024Today4/29/2024Next Earnings (Estimated)5/09/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:MBX CUSIPN/A CIKN/A Webmicrobix.com Phone+1-905-3618910FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.03 Trailing P/E Ratio10.83 Forward P/E Ratio16.23 P/E GrowthN/ANet IncomeC$3.72 million Net Margins16.57% Pretax MarginN/A Return on Equity14.66% Return on Assets1.87% Debt Debt-to-Equity Ratio24.53 Current Ratio8.53 Quick Ratio5.57 Sales & Book Value Annual SalesC$22.42 million Price / Sales1.98 Cash FlowC$0.08 per share Price / Cash Flow4.13 Book ValueC$0.20 per share Price / Book1.63Miscellaneous Outstanding Shares136,550,000Free FloatN/AMarket CapC$44.38 million OptionableNot Optionable Beta0.28 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Cameron L. GroomePresident, CEO & DirectorMr. James S. CurrieChief Financial OfficerDr. Kenneth Hughes Ph.D.Chief Operating OfficerDr. Mark Luscher Ph.D.Senior Vice President of Scientific AffairsMr. Philip CasselliSenior Vice President of Sales, Business Development & MarketingMr. Christopher B. LobbCompliance Officer, General Counsel & SecretaryMore ExecutivesKey CompetitorsHelix BioPharmaTSE:HBPBriaCell TherapeuticsTSE:BCTSmall PharmaCVE:DMTProMIS NeurosciencesTSE:PMNEmerald Health TherapeuticsCVE:EMHView All CompetitorsInsidersBo HollasSold 100,000 sharesTotal: C$39,250.00 ($0.39/share)Steven Trevor HagermanSold 5,500 sharesTotal: C$2,172.50 ($0.40/share)Cameron Lionel GroomeSold 119,500 sharesTotal: C$47,023.25 ($0.39/share)Jennifer Anne StewartBought 13,945 shares on 1/22/2024Total: C$5,996.35 ($0.43/share)View All Insider Transactions MBX Stock Analysis - Frequently Asked Questions Should I buy or sell Microbix Biosystems stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Microbix Biosystems in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MBX shares. View MBX analyst ratings or view top-rated stocks. How have MBX shares performed in 2024? Microbix Biosystems' stock was trading at C$0.39 at the beginning of 2024. Since then, MBX shares have decreased by 16.7% and is now trading at C$0.33. View the best growth stocks for 2024 here. When is Microbix Biosystems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our MBX earnings forecast. How were Microbix Biosystems' earnings last quarter? Microbix Biosystems Inc. (TSE:MBX) posted its quarterly earnings results on Wednesday, February, 14th. The company reported $0.02 EPS for the quarter. The company had revenue of $8.41 million for the quarter, compared to the consensus estimate of $8.10 million. Microbix Biosystems had a trailing twelve-month return on equity of 14.66% and a net margin of 16.57%. What other stocks do shareholders of Microbix Biosystems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbix Biosystems investors own include TransAlta Renewables (RNW), Organigram (OGI), Dynavax Technologies (DVAX), Heat Biologics (HTBX), VEON (VEON), Vaxart (VXRT), Wajax (WJX), BlackBerry (BB) and Canadian Western Bank (CWB). How do I buy shares of Microbix Biosystems? Shares of MBX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:MBX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbix Biosystems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.